HPV Vaccine Tied to Lower Cancer Risk in Men, Too
About one in five males older than 15 years is infected with a high-risk HPV type. Among males ages 9 to 26 years, those who received the 9-valent HPV vaccine had a lower risk of a composite of HPV-related cancers compared with those who were unvaccinated. These results indicate that HPV vaccination should be sex-neutral,…
